Therapeutic promise of CAR-T cell bispecific engagers against SARS-CoV-2
A new paper describes a novel method, using a specific molecule to engage T cell receptors and the virus receptor, the angiotensin-converting enzyme 2, at the same time.
Stay updated with breaking news from Cell Membrane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new paper describes a novel method, using a specific molecule to engage T cell receptors and the virus receptor, the angiotensin-converting enzyme 2, at the same time.
Working with tiny bacteria, Michigan State University researchers led by Lee Kroos have made a discovery that could have big implications for biology.
For more than two decades, University of Alabama at Birmingham researcher Susan Bellis, Ph.D., has studied how the addition of sialic acid to various proteins increases cancer resistance and oncogenicity.
Researchers demonstrate that avasimibe-mediated inhibition of ACAT blocks the entry and fusion of SARS-CoV-2 in different cell types.
Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019.